General Announcement::Takeda announces launch of exchange offer for $4.5 Billion Outstanding Senior Notes

Issuer & Securities

Issuer/ Manager
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Securities
TAKEDAPHARUS$1.25B 4%211126A - US874060AN65 - JEQB
TAKEDAPHARUS$1.25B 4%211126R - USJ8129EAW87 - ZSMB
TAKEDAPHARUS$1.5B4.4%231126A - US874060AR79 - 8E1B
TAKEDAPHARUS$1.5B4.4%231126R - USJ8129EAX60 - LJLB
TAKEDAPHARUS$1.75B 5%281126A - US874060AU09 - HQGB
TAKEDAPHARUS$1.75B 5%281126R - USJ8129EAY44 - Y5RB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
14-Nov-2019 18:47:35
Status
New
Announcement Sub Title
Takeda announces launch of exchange offer for $4.5 Billion Outstanding Senior Notes
Announcement Reference
SG191114OTHRD7OG
Submitted By (Co./ Ind. Name)
Nobutaka Ura
Designation
Head of SEC Reporting
Description (Please provide a detailed description of the event in the box below)
Takeda Pharmaceutical Company Limited (Takeda) today announces that, based on its determination as of November 12, 2019, it has launched an offer to exchange new registered notes for any and all of the outstanding unregistered notes that it issued on November 19, 2018 in a private placement pursuant to Rule 144A and Regulation S under the U.S. Securities Act of 1933, as amended (the Securities Act).

Attachments

Launch of Exchange offer_111419.pdf
Total size =224K